- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.89 Å
- Oligo State
- hetero-2-2-mer
- Ligands
- 2 x ZNI: (1R,5S,6r)-N-[(1P,7S,9S,13S,20M)-20-{5-(4-cyclopropylpiperazin-1-yl)-2-[(1S)-1-methoxyethyl]pyridin-3-yl}-21-ethyl-17,17-dimethyl-8,14-dioxo-15-oxa-4-thia-9,21,27,28-tetraazapentacyclo[17.5.2.1~2,5~.1~9,13~.0~22,26~]octacosa-1(24),2,5(28),19,22,25-hexaen-7-yl]-3-oxabicyclo[3.1.0]hexane-6-carboxamide(Non-covalent)
- 2 x AF3: ALUMINUM FLUORIDE(Non-covalent)
AF3.3: 12 residues within 4Å:- Chain C: S.13, G.14, K.17, Y.33, P.35, T.36, T.59, A.60, G.61, Q.62
- Ligands: MG.4, GDP.5
No protein-ligand interaction detected (PLIP)AF3.6: 12 residues within 4Å:- Chain D: S.13, G.14, K.17, Y.33, P.35, T.36, T.59, A.60, G.61, Q.62
- Ligands: MG.7, GDP.8
No protein-ligand interaction detected (PLIP)- 2 x MG: MAGNESIUM ION(Non-covalent)
MG.4: 6 residues within 4Å:- Chain C: K.17, S.18, T.36, D.58
- Ligands: AF3.3, GDP.5
4 PLIP interactions:2 interactions with chain C, 2 Ligand-Water interactions- Metal complexes: C:S.18, C:T.36, H2O.12, H2O.12
MG.7: 5 residues within 4Å:- Chain D: K.17, S.18, T.36
- Ligands: AF3.6, GDP.8
4 PLIP interactions:2 interactions with chain D, 2 Ligand-Water interactions- Metal complexes: D:S.18, D:T.36, H2O.17, H2O.17
- 2 x GDP: GUANOSINE-5'-DIPHOSPHATE(Non-covalent)
GDP.5: 23 residues within 4Å:- Chain C: A.12, S.13, G.14, V.15, G.16, K.17, S.18, A.19, F.29, V.30, D.31, E.32, Y.33, D.34, N.117, K.118, D.120, L.121, S.146, A.147, K.148
- Ligands: AF3.3, MG.4
21 PLIP interactions:21 interactions with chain C- Hydrogen bonds: C:G.14, C:V.15, C:G.16, C:K.17, C:S.18, C:A.19, C:V.30, C:E.32, C:N.117, C:K.118, C:K.118, C:S.146, C:A.147, C:K.148
- Water bridges: C:S.18, C:D.34, C:T.36
- Salt bridges: C:K.17, C:D.120
- pi-Stacking: C:F.29, C:F.29
GDP.8: 23 residues within 4Å:- Chain D: A.12, S.13, G.14, V.15, G.16, K.17, S.18, A.19, F.29, V.30, D.31, E.32, Y.33, D.34, N.117, K.118, D.120, L.121, S.146, A.147, K.148
- Ligands: AF3.6, MG.7
21 PLIP interactions:21 interactions with chain D- Hydrogen bonds: D:A.12, D:G.14, D:V.15, D:G.16, D:K.17, D:S.18, D:A.19, D:V.30, D:N.117, D:K.118, D:K.118, D:S.146, D:A.147, D:K.148
- Water bridges: D:S.18, D:D.34, D:T.36
- Salt bridges: D:K.17, D:D.120
- pi-Stacking: D:F.29, D:F.29
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Pourfarjam, Y. et al., Crystal structure of KRAS G12S in a transition state mimetic complex with CYPA and RMC-7977. To Be Published
- Release Date
- 2024-11-06
- Peptides
- Peptidyl-prolyl cis-trans isomerase A: AB
Isoform 2B of GTPase KRas: CD - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
BB
DC
AD
C
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.89 Å
- Oligo State
- hetero-2-2-mer
- Ligands
- 2 x ZNI: (1R,5S,6r)-N-[(1P,7S,9S,13S,20M)-20-{5-(4-cyclopropylpiperazin-1-yl)-2-[(1S)-1-methoxyethyl]pyridin-3-yl}-21-ethyl-17,17-dimethyl-8,14-dioxo-15-oxa-4-thia-9,21,27,28-tetraazapentacyclo[17.5.2.1~2,5~.1~9,13~.0~22,26~]octacosa-1(24),2,5(28),19,22,25-hexaen-7-yl]-3-oxabicyclo[3.1.0]hexane-6-carboxamide(Non-covalent)
- 2 x AF3: ALUMINUM FLUORIDE(Non-covalent)
- 2 x MG: MAGNESIUM ION(Non-covalent)
- 2 x GDP: GUANOSINE-5'-DIPHOSPHATE(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Pourfarjam, Y. et al., Crystal structure of KRAS G12S in a transition state mimetic complex with CYPA and RMC-7977. To Be Published
- Release Date
- 2024-11-06
- Peptides
- Peptidyl-prolyl cis-trans isomerase A: AB
Isoform 2B of GTPase KRas: CD - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
BB
DC
AD
C